全文获取类型
收费全文 | 476篇 |
免费 | 37篇 |
国内免费 | 105篇 |
专业分类
儿科学 | 28篇 |
妇产科学 | 7篇 |
基础医学 | 45篇 |
口腔科学 | 32篇 |
临床医学 | 108篇 |
内科学 | 107篇 |
皮肤病学 | 6篇 |
神经病学 | 11篇 |
特种医学 | 69篇 |
外科学 | 57篇 |
综合类 | 37篇 |
预防医学 | 22篇 |
眼科学 | 5篇 |
药学 | 51篇 |
中国医学 | 1篇 |
肿瘤学 | 32篇 |
出版年
2021年 | 9篇 |
2020年 | 2篇 |
2019年 | 6篇 |
2018年 | 7篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 11篇 |
2014年 | 12篇 |
2013年 | 22篇 |
2012年 | 13篇 |
2011年 | 13篇 |
2010年 | 24篇 |
2009年 | 20篇 |
2008年 | 7篇 |
2007年 | 61篇 |
2006年 | 13篇 |
2005年 | 24篇 |
2004年 | 17篇 |
2003年 | 13篇 |
2002年 | 14篇 |
2001年 | 6篇 |
2000年 | 13篇 |
1999年 | 6篇 |
1998年 | 45篇 |
1997年 | 35篇 |
1996年 | 38篇 |
1995年 | 18篇 |
1994年 | 22篇 |
1993年 | 15篇 |
1992年 | 11篇 |
1991年 | 3篇 |
1990年 | 11篇 |
1989年 | 13篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 12篇 |
1985年 | 5篇 |
1984年 | 3篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 4篇 |
1976年 | 6篇 |
1975年 | 3篇 |
1974年 | 1篇 |
1971年 | 1篇 |
1965年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有618条查询结果,搜索用时 0 毫秒
21.
Thrombopoietin (TPO) or MpI ligand is known to stimulate megakaryocyte (MK) proliferation and differentiation. To identify the earliest human hematopoietic cells on which TPO acts, we cultured single CD34+Thy- 1+Lin- adult bone marrow cells in the presence of TPO alone, with TPO and interleukin-3 (IL-3), or with TPO and c-kit ligand (KL) in the presence of a murine stromal cell line (Sys1). Two distinct growth morphologies were observed: expansion of up to 200 blast cells with subsequent differentiation to large refractile CD41b+ MKs within 3 weeks or expansion to 200-10,000 blast cells, up to 25% of which expressed CD34. The latter blast cell expansions occurred over a 3- to 6-week period without obvious MK differentiation. Morphological staining, analysis of surface marker expression, and colony formation analysis revealed that these populations consisted predominantly of cells committed to the myelomonocytic lineage. The addition of IL-3 to TPO-containing cultures increased the extent of proliferation of single cells, whereas addition of KL increased the percentage of CD34+ cells among the expanding cell populations. Production of multiple colony- forming unit-MK from single CD34+Thy-1+Lin- cells in the presence of TPO was also demonstrated. In limiting dilution assays of CD34+Lin- cells, TPO was found to increase the size and frequency of cobblestone areas at 4 weeks in stromal cultures in the presence of leukemia inhibitory factor and IL-6. In stroma-free cultures, TPO activated a quiescent CD34+Lin-Rhodamine 123lo subset of primitive hematopoietic progenitor cells into cycle, without loss of CD34 expression. These data demonstrate that TPO acts directly on and supports division of cells more primitive than those committed to the MK lineage. 相似文献
22.
23.
24.
25.
Auber ML; Horwitz LJ; Blaauw A; Khorana S; Tucker S; Woods T; Warmuth M; Dicke KA; McCredie KB; Spitzer G 《Blood》1988,71(1):166-172
Relatively nonmyelotoxic drugs and drug combinations were investigated for their ability to eliminate malignant cells from human bone marrow. In vitro 90% inhibitory concentration (IC90) doses were established on granulocyte macrophage colony-forming units (GM-CFU) in culture of bone marrow by using the GM-CFU assay for the following drugs: 4- hydroperoxycyclophosphamide (4-HC), Adriamycin, L-asparaginase, bleomycin, hydrocortisone, VP-16, spirogermanium, Taxol, and vincristine. The leukemic cell kill efficiency of these drugs at IC90 doses was compared with that of 4-HC on acute lymphoid leukemia (ALL) cell lines by using the limiting-dilution assay. Under these conditions, no single drug was superior to 4-HC. To increase the in vitro effect in leukemic cell kill, combinations of vincristine with hydrocortisone, Adriamycin, VP-16, and 4-HC were investigated. Vincristine at 1 to 5 micrograms/mL increased the marrow cytotoxicity of hydrocortisone, Adriamycin, and VP-16, but it was protective (subadditive) with 4-HC. Vincristine and 4-HC in combination was additive to supraadditive on ALL cell lines, increased the leukemic cell kill by one to two logs above 4-HC alone at IC90 doses (P less than .05), and was not affected by the addition of excess marrow cells. The recommended doses for chemopurging in clinical studies are vincristine, 1 to 5 micrograms/mL, plus 4-HC, 5 micrograms/mL. 相似文献
26.
Ryan J. Marek Yossef S. Ben-Porath Julie Merrell Kathleen Ashton Leslie J. Heinberg 《Obesity surgery》2014,24(4):631-639
Background
Presurgical psychological screening of bariatric surgery candidates includes some form of standardized psychological assessment. However, associations between presurgical psychological screening and postoperative outcome have not been extensively studied. Here, we explore associations between presurgical Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF) scores and early postoperative Somatic Concerns, Psychological Distress, and Maladaptive Eating Behaviors.Methods
The sample consisted of male (n?=?238) and female (n?=?621) patients who were administered the MMPI-2-RF at their presurgical psychological evaluation and received bariatric surgery. Patients were evaluated at their 1- and 3-month postoperative appointments.Results
Confirmatory factor analysis indicated that three latent constructs—somatic concerns, psychological distress, and maladaptive eating behaviors—were represented by responses to a postoperative assessment and that these constructs could be measured consistently over time. Presurgical scores on MMPI-2-RF scales measuring internalizing dysfunction were associated with more psychological distress at postoperative follow-ups, scores on scales measuring somatization were associated with more postoperative somatic concerns, and scores on scales assessing emotional/internalizing, behavioral/externalizing, cognitive complaints, and thought dysfunction prior to surgery were associated with maladaptive eating behaviors after surgery.Conclusions
In conjunction with a presurgical psychological interview, the MMPI-2-RF provides information that can assist in anticipating postoperative outcomes and inform efforts to prevent them. 相似文献27.
前列腺特异抗原研究进展与挑战(摘要) 总被引:1,自引:0,他引:1
前列腺特异抗原(PSA)发现四分之一世纪以来,已成为诊断前列腺癌最有价值的肿瘤标志物。前列腺癌在男性癌症发病中占首位。自从80年代中期第一代检测PSA的方法问世以来,前列腺癌的发病率有了显著改变。这部分归功于PSA检测的增加,从而使前列腺癌得到早期诊断,这有利于将癌症控制在发病早期,增加治愈的可能性。虽然PSA是一个有效的肿瘤标志物,并具有器官特异性,但其癌症特异性不高。PSA升高也可见于其他良性前列腺疾病,尤其当PSA浓度在4~10μg/L时。这个浓度范围被称为“诊断灰色区域”。对PSA分子结构的研究主要集中… 相似文献
28.
29.
30.